Shenyang Sansheng Pharmaceutical Co., Ltd. is wholly owned by Taiwan, Hong Kong and Macao.

Shenyang Sansheng Pharmaceutical Co., Ltd. was established in 1993, which is a high-tech enterprise integrating R&D, production and sales of biopharmaceuticals. The company develops recombinant or genetically engineered protein drugs to meet the market demand for clinical treatment of kidney disease, tumor, tumor support therapy, and other inflammatory and infectious diseases.

Sales and production of Shenyang Sansheng Pharmaceutical:

The company's production base is located in Shenyang Economic and Technological Development Zone, with a workshop area of 3, square meters and passed the national GMP certification. The production base produces four kinds of products in large quantities, such as Ebbio, Tebio, Intveen and Yingluoyin, to meet the clinical application and commercial demand. The company plans to build a new factory building and improve production capacity to meet the growing market demand.

the company's marketing team consists of 145 professionals, covering major cities in China. Products are sold to more than 8 hospitals, clinics and dialysis centers in China through about 8 commercial companies. The company has been providing high-quality, safe and reliable biopharmaceuticals to the China market, and the brand of Shenyang Sansheng has been widely recognized.

The above content is referenced by:

Baidu Encyclopedia-Shenyang Sansheng Pharmaceutical Co., Ltd.